The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport

被引:67
作者
Liu, J
DeYoung, SM
Hwang, JB
O'Leary, EE
Saltiel, AR
机构
[1] Univ Michigan, Med Ctr, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Ctr, Inst Life Sci, Dept Physiol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1074/jbc.M300664200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies suggest that the stimulation of glucose transport by insulin involves the tyrosine phosphorylation of c-Cbl and the translocation of the c-Cbl/CAP complex to lipid raft subdomains of the plasma membrane. We now demonstrate that Cbl-b also undergoes tyrosine phosphorylation and membrane translocation in response to insulin in 3T3-L1 adipocytes. Ectopic expression of APS facilitated insulin-stimulated phosphorylation of tyrosines 665 and 709 in Cbl-b. The phosphorylation of APS produced by insulin drove the translocation of both c-Cbl and Cbl-b to the plasma membrane. Like c-Cbl, Cbl-b associates constitutively with CAP and interacts with Crk upon insulin stimulation. Cbl proteins formed homo- and heterodimers in vivo, which required the participation of a conserved leucine zipper domain. A Cbl mutant incapable of dimerization failed to interact with APS and to undergo tyrosine phosphorylation in response to insulin, indicating an essential role of Cbl dimerization in these processes. Thus, both c-Cbl and Cbl-b can initiate a phosphatidylinositol 3-kinase/protein kinase B-independent signaling pathway critical to insulin-stimulated GLUT4 translocation.
引用
收藏
页码:36754 / 36762
页数:9
相关论文
共 33 条
  • [1] The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor
    Ahmed, Z
    Smith, BJ
    Pillay, TS
    [J]. FEBS LETTERS, 2000, 475 (01) : 31 - 34
  • [2] Andoniou CE, 1996, ONCOGENE, V12, P1981
  • [3] Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
    Bachmaier, K
    Krawczyk, C
    Kozieradzki, I
    Kong, YY
    Sasaki, T
    Oliveira-dos-Santos, A
    Mariathasan, S
    Bouchard, D
    Wakeham, A
    Itie, A
    Le, J
    Ohashi, PS
    Sarosi, I
    Nishina, H
    Lipkowitz, S
    Penninger, JM
    [J]. NATURE, 2000, 403 (6766) : 211 - 216
  • [4] Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl - A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor
    Bartkiewicz, M
    Houghton, A
    Baron, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 30887 - 30895
  • [5] CAP defines a second signalling pathway required for insulin-stimulated glucose transport
    Baumann, CA
    Ribon, V
    Kanzaki, M
    Thurmond, DC
    Mora, S
    Shigematsu, S
    Bickel, PE
    Pessin, JE
    Saltiel, AR
    [J]. NATURE, 2000, 407 (6801) : 202 - 207
  • [6] Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10
    Chiang, SH
    Baumann, CA
    Kanzaki, M
    Thurmond, DC
    Watson, RT
    Neudauer, CL
    Macara, IG
    Pessin, JE
    Saltiel, AR
    [J]. NATURE, 2001, 410 (6831) : 944 - 948
  • [7] Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases
    Deckert, M
    Elly, C
    Altman, A
    Liu, YC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) : 8867 - 8874
  • [8] Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation
    Elly, C
    Witte, S
    Zhang, ZH
    Rosnet, O
    Lipkowitz, S
    Altman, A
    Liu, YC
    [J]. ONCOGENE, 1999, 18 (05) : 1147 - 1156
  • [9] Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells
    Feshchenko, EA
    Langdon, WY
    Tsygankov, AY
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) : 8323 - 8331
  • [10] The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk
    Garcia-Guzman, M
    Larsen, E
    Vuori, K
    [J]. ONCOGENE, 2000, 19 (35) : 4058 - 4065